[High-dose tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary

Li-hui Ren1, Jian-jun Peng, Hui-ming Ye

  • 1Department of Cardiology, Beijing Shijitan Hospital, Beijing, China.

Zhonghua Yi Xue Za Zhi
|September 5, 2012
PubMed

Insights

High-dose tirofiban significantly improved ST-segment resolution and left ventricular ejection fraction in ST-elevation myocardial infarction patients undergoing primary PCI, without increasing hemorrhage risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • ST-elevation myocardial infarction (STEMI) is a critical condition requiring rapid reperfusion.
  • Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
  • Platelet aggregation inhibition is crucial during primary PCI.

Purpose of the Study:

  • To assess the clinical outcomes of high-dose tirofiban therapy.
  • To compare high-dose tirofiban with standard-dose tirofiban in STEMI patients undergoing primary PCI.

Main Methods:

  • A randomized trial involving 104 STEMI patients undergoing primary PCI.
  • Patients were assigned to either high-dose or normal-dose tirofiban groups.
  • Evaluated ECG ST-segment resolution and left ventricular ejection fraction (LVEF) at 90 days post-PCI.

Main Results:

  • High-dose tirofiban group showed significantly improved ST-segment resolution post-PCI (38% ± 12% vs 34% ± 13%, P < 0.05).
  • LVEF significantly improved in the high-dose group by day 90 (60.1% ± 1.1% vs 56.0% ± 1.2%, P < 0.05).
  • No significant difference in major or moderate hemorrhage rates between groups.

Conclusions:

  • High-dose tirofiban enhances myocardial reperfusion and clinical outcomes in STEMI patients undergoing primary PCI.
  • Supports the benefit of intensified platelet inhibition in this patient population.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...